Unilever has announced that it has signed an agreement to acquire the Fluocaril and Parogencyl oral care brands from Procter & Gamble.
The two brands are well-known therapeutics brands sold in the Pharmacy channel, primarily in France and Spain, with a product portfolio that enjoys strong endorsement from health professionals, Unilever said.
Fluocaril offers oral care solutions specialising in protection against cavities, while Parogencyl tackles gum issues.
The company said that the acquisition will give it a leading position in oral care within the French pharmacy channel as well as strong positions in Spain.
‘With their powerful brand heritage, high awareness and sound reputation amongst dentists, these brands are a great complement to Unilever’s existing oral care portfolio,’ a statement from the company read.
Terms of the deal were not disclosed, but the acquisition is expected to close in Q2 2019.
© 2019 Checkout – your source for the latest Irish retail news. Article by Aidan O’Sullivan. Click sign-up to subscribe to Checkout.